LOS ANGELES, April 3, 2014 /PRNewswire/ -- Medbox, Inc.
(OTCQB: MDBX) (www.medbox.com), a leader in providing consulting
services and patented medicine storage and dispensing systems to
the medical and retail industries, today announced that effective
with the opening of the market on Thursday,
April 3, 2014, the company's common stock will be traded on
the OTCQB® tier of the OTC markets.
The stock will continue to trade under the ticker symbol
"MDBX".
The OTCQB® marketplace offers informed trading for securities
for smaller or developing companies that are reporting and are
current in disclosures to a U.S. regulator (SEC, Bank, or
Insurance).
"Moving to the OTCQB® tier of the OTC markets is an
important step, providing greater liquidity to our shareholders,"
commented Dr. Bruce Bedrick, Chief
Executive Officer of Medbox. "This transition also underscores the
steps Medbox has taken to establish itself as the clear leader in
the emerging marijuana sector, including becoming a fully
reporting, SEC-compliant company. As we continue to execute, we
hope to move to a national listing on another exchange by the end
of 2014."
About Medbox, Inc:
Medbox
is a leader in the development, sales and service of automated,
biometrically controlled dispensing and storage systems for
medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned
subsidiary, Medicine Dispensing Systems, offers their patented
systems, software and consulting services to pharmacies, medical
dispensaries and local governments in the U.S. In addition, through
its wholly owned subsidiary, Vaporfection International, Inc.
(www.vaporfection.com), the company offers an industry award
winning medical vaporizer product.
Forward-Looking Statements: The statements in this press release
constitute forward-looking statements within the meaning of federal
securities laws. Such statements are based on our current beliefs
and expectations and are inherently subject to significant
business, economic and competitive uncertainties and contingencies,
many of which are beyond our control. In addition, such
forward-looking statements are subject to assumptions with respect
to future business strategies and decisions that are subject to
change. Potential risks and uncertainties include, but are not
limited to, technical advances in the industry as well as political
and economic conditions present within the industry. We do not take
any obligation to update any forward-looking statement to reflect
events or developments after a forward-looking statement was
made.
Medbox, Inc. is a publicly traded company, and is quoted on the
OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact (800) 762-1452 or
go online to: http://www.medbox.com.
Contacts:
Investor Relations:
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@haydenir.com
SOURCE Medbox, Inc.